This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Els, Th. Articles by Hennerici, M. Search for Related Content PubMed PubMed Citation Articles by Els, Th. Articles by Hennerici, M. Related Collections Other diagnostic testing Acute Cerebral Infarction Brain Circulation and Metabolism Pathology of Stroke

(Stroke. 2001;32:43.)
© 2001 American Heart Association, Inc.

Original Contributions

Spermidine: A Predictor for Neurological Outcome and Infarct Size in Focal Cerebral Ischemia?

Th. Els, MD; J. Bruckmann, MD; G. Röhn, PhD; M. Daffertshofer, MD; J. Schulte Mönting, PhD; R.-I. Ernestus, MD M. Hennerici, MD

From the Department of Neurology (Th.E.), Institute for Medical Statistics and Informatics (J.S.M.), University of Freiburg; the Department of Neurology (J.B., M.D., M.H.), University of Heidelberg, Klinikum Mannheim; and the Department of Neurosurgery (G.R., R.-I.E.), University of Cologne (Germany).

Correspondence to Thomas Els, MD, Department of Neurology, University of Freiburg, Breisacher Str 64, D-79106 Freiburg, Germany. E-mail ELS{at}nz.ukl.uni-freiburg.de

Background and Purpose—Polyamines are mainly restricted to the intracellular space. During focal cerebral ischemia, polyamines are released from the intracellular compartment. Experimental studies have implicated a marked elevation in brain tissue and blood. The aim of our study was to investigate whether the elevation of polyamines in the blood of patients with focal cerebral ischemia correlates with the clinical outcome and the infarct volume.

Methods—Polyamines were measured in 16 patients with focal cerebral ischemia and in 8 healthy control subjects. Blood samples for polyamine measurement were taken at admission and at fixed time points for the next 28 days. Polyamines were analyzed in red blood cells by a high-pressure liquid chromatography system. Clinical findings were recorded with the NIH Stroke Scale score. Volume of infarction was analyzed from cranial CT at admission and on days 4 to 6 after ischemia.

Results—A significant increase of the spermidine level in the peripheral blood could be observed in all patients with focal cerebral ischemia as compared with control subjects (P<0.01), starting with the admission. Spermidine values correlated positively with the clinical outcome at several time points in the first 48 hours (r=0.90 to 0.40; P<0.01) and with the infarct volume in cranial CT on days 4 to 6 (r=0.91; P<0.01).

Conclusions—As hypothesized from experimental data, polyamine levels in blood increase in patients after focal cerebral ischemia. The results indicate that the peripheral spermidine level is closely associated with the clinical outcome as well as with the infarction volume. Therefore, polyamines may be used as a novel predictor for the prognosis of patients with focal cerebral ischemia.

Key Words: biological markers • cerebral ischemia, focal • outcome • polyamines